Trials / Not Yet Recruiting
Not Yet RecruitingNCT05364736
Effect of Prebiotics on Blood Pressure Management
An Interventional Study for the Effects of Highland Barley β-glucan on the Management of Hypertension and Cardiovascular Risk
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Sun Yat-sen University · Academic / Other
- Sex
- All
- Age
- 30 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
This survey is designed to investigate the effect of highland barley β-glucan supplementation on the regulatory of blood pressure, gut microbiota and cardiovascular risk fators in subjects with hypertention.
Detailed description
Highland barley β-glucan belongs to the group of prebiotics and has been found to be associated with multiple health benefits. However, its protective role in subjects with hypertension are remain unclear. This study aims to examine the effect of 12-week prebiotics supplementation on blood pressure management in subjects with hypertension. By understanding the mechanism by which prebiotics exert the beneficial effects, we can better control the rising prevalence of hypertension, which is a major risk factor for cardiovascular diseases.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Highland barley β-glucan dietary supplement | 100 mL oral liquid mainly containing highland barley β-glucan once daily for 12 weeks |
| OTHER | Placebo controls | Placebo with a similar appearance and taste to highland barley β-glucan supplement |
Timeline
- Start date
- 2022-10-17
- Primary completion
- 2023-12-31
- Completion
- 2030-12-31
- First posted
- 2022-05-06
- Last updated
- 2022-05-06
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05364736. Inclusion in this directory is not an endorsement.